Verthermia, Inc., a whole body hyperthermia medical device leader commercializing safe and effective complementary treatments for solid tumor cancer in the metastatic phase, announces that CEO Steve Scott will present at the 2016 BIO Investor Forum taking place October 18-19, 2016 in San Francisco. Heatt system for solid tumor cancers from Verthermia SAN DIEGO – Oct. 15, ...Read more
Verthermia has developed a procedure to treat cancer using heat, replicating the body’s natural defense against disease.
This technique of initiating an artificial fever creates a cytotoxic environment for cancer cells while leaving normal healthy cells unharmed.
Verthermia, Inc. has selected the eClinicalOS data management platform from Merge eClinical for its clinical trial exploring the potential of whole body hyperthermia as a standalone treatment for women with Stage III or IV ovarian cancer. For more information, read Merge’s press release.Read more
Los Gatos, Calif. (Oct. 27, 2014) – In January, 2014 Verthermia, Inc. obtained clearance from FDA and began a Phase I clinical trial exploring the potential of whole body hyperthermia (WBH) as a standalone treatment for Stage III or IV ovarian cancer. The company has completed eight treatments as of October, 2014. The use of heat ...Read more